Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Acetylcysteine and Buthionine Sulfoximine

Research Papers that Mention the Interaction

Au, BSO and radiation also significantly decreased breast cancer cell migration and invasion in a thiol-dependent manner that could be inhibited by NAC.
Radiation Research  •  2016  |  View Paper
We found that apoptosis was greatly enhanced by BSO , blocked by NAC , and accompanied by poly(ADP-ribose) polymerase cleavage and activation of caspase-3, caspase-8, and caspase-9.
Clinical Cancer Research  •  2010  |  View Paper
Cotreatment with N-acetyl-l-cysteine , a GSH precursor, ameliorated LCA toxicity, whereas cotreatment with buthionine sulfoximine , a GSH synthesis blocker, exacerbated it.
Molecular Pharmacology  •  2007  |  View Paper
The dialysate concentrations of both glutathione and cysteine decreased during concomitant treatment with BSO and NAC or OTC.
Cancer Chemotherapy and Pharmacology  •  2000  |  View Paper
BSO potentiated the observed effect on α1-AR while NAC ameliorated these effects.
Scientific reports  •  2020  |  View Paper
Strikingly, co-treatment of MSCs with NAC (5 mM) and BSO + 6-OHDA significantly reduced the expression of OS and cell death markers but were unable to restore the expression of GPX1 compared to the expression in untreated or treated cells with NAC only.
Molecular Biology Reports  •  2019  |  View Paper
However, NAC was still able to block z-FA-CMK toxicity in Jurkat T cells in the presence of BSO , indicating that the protective effect of NAC does not involve GSH biosynthesis.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2017  |  View Paper
Treatment of HTLA-Chr cells with L-Buthionine-sulfoximine , an inhibitor of GSH biosynthesis, markedly reduces their tumorigenic potential that is instead enhanced by the exposure to N-Acetylcysteine , able to promote GSH synthesis.
Oncotarget  •  2016  |  View Paper
Combinational drug treatment with N-Acetyl-L-cysteine and L-buthioninesulfoximine strongly counteracted effect of 1 and 2, while the same treatment rather enhanced cytotoxicity of Pt(IV) analogues.
Anti-cancer agents in medicinal chemistry  •  2016  |  View Paper
Inversely, pre-treatment of cells with BSO augmented N-Me-α-MeDA-induced neurotoxicity, but only slightly affected NAC neuroprotection.
Toxicology letters  •  2013  |  View Paper
Show More